Clinical Trial Update: Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Lispro Mid Mixture (MM) intensive therapy with progressive dose titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic Insulin Aspart 30/70 (S019) (insulin aspart)
• Lispro Low Mixture (LM) (insulin lispro)
• Lispro Mid Mixture (MM) (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2010-04-27